V

Viamet Pharmaceuticals

6 employees

Viamet discovers and develops small molecule inhibitors via an enzyme binding approach for the treatment of various diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Medical Device
Pharmaceutical

Date founded

2018

Funding rounds raised

Total raised

$60M

from 8 investors over 8 rounds

V

Viamet Pharmaceuticals raised $2M on June 4, 2015

Investors: united-states-department-of-defense

V

Viamet Pharmaceuticals raised $60M on October 21, 2014

Investors: Astellas Venture Capital L.L.C., Intersouth Partners and Lilly Ventures

V

Viamet Pharmaceuticals raised $25M on July 7, 2009

Investors: Astellas Venture Capital L.L.C., Intersouth Partners and Lilly Ventures

V

Viamet Pharmaceuticals raised $4M on June 7, 2007

Investors: Intersouth Partners

FAQ